EU agency says Omicron cases so far appear 'mostly mild'. Then cautions
- The European Medicines Agency (EMA) said more data is required to determine the severity of coronavirus disease (Covid-19) caused by the Omicron variant that was first detected in South Africa last month.
The European Medicines Agency (EMA) on Thursday said cases of Omicron variant so far appear to be “mostly mild” but cautioned that the investigation to arrive at a definite conclusion is still underway. Marco Cavaleri, EMA's head of biological health threats and vaccines strategy, told a regular press briefing that more data is required to determine the severity of coronavirus disease (Covid-19) caused by the Omicron variant first detected in South Africa last month.
"Cases appear to be mostly mild, however, we need to gather more evidence to determine whether the spectrum of disease severity caused by Omicron is different (to) that of all the variants that have been circulating so far," Cavaleri said.
The agency stressed that the highly transmissible Delta variant, on which experts have enough data, should remain the main concern. It further stated that the agency doesn't have enough data on the impact of the Omicron variant on the effectiveness of the approved Covid-19 vaccines.
"We are reiterating a call to all citizens to complete their primary Covid-19 vaccination and, for those who are eligible, to get a booster shot," the EMA said.
The update from the European agency comes at a time when researchers around the world are scrambling to gather more data on this new variant of concern which has prompted countries to tighten travel restrictions in a bid to contain the spread of Omicron.
The EMA said it has been, meanwhile, working with vaccines manufacturers on contingency plans to "define requirements for advancing potential variant vaccines", adding that it was too early to comment on the possible need to change vaccine composition.
Citing epidemiological data, the EMA also raised concern over an increase in infections and hospitalisation of children aged 5-11 years in recent months. "While children at risk of severe Covid-19 should be given priority, all children in this age group should be considered for vaccination," it said.
North Korea is ramping up the production of drugs and medical supplies to combat the Covid-19 pandemic, which has wreaked havoc. According to the Korean Central News Agency on Thursday, North Korea is also increasing the production of traditional Korean medicines used to reduce fever and pain. In the capital city of Pyongyang and nearby regions, factories are churning out more injections, medicines and thermometers and other medical supplies.
Veteran diplomat Bridget Brink, who was nominated by US President Joe Biden to be the country's next ambassador to war-hit Ukraine, was on Wednesday (local time) given a unanimous approval by the Senate Foreign Relations Committee for appointment to the post, which means that she just a step away from being Washington's new representative in the east European nation. She was nominated by Biden on April 25.
Officials in Spain and Portugal announced on Wednesday that they have detected around 32 suspected cases of monkeypox, days after the UK reported new cases that have triggered concerns that there may be an undetected transmission in parts of Europe. Portugal had five confirmed and 20 suspected cases, Spain eight suspected cases and UK seven confirmed infections as on Wednesday.
US secretary of state Antony Blinken on Wednesday met Pakistan's foreign minister Bilawal Bhutto Zardari at the UN headquarters and their talks focussed on regional security as well as strengthening bilateral economic and commercial ties. Bilawal is on a maiden visit to the US at the invitation of Blinken to attend the ministerial meeting on the “Global Food Security Call to Action” to be held at the United Nations later on Wednesday.
The World Bank said on Wednesday it will make $30 billion available to help stem a food security crisis threatened by Russia's war in Ukraine, which has cut off most grain exports from the two countries. The total will include $12 billion in new projects and over $18 billion funds from existing food and nutrition-related projects that have been approved but have not yet been disbursed, the bank said.